BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 34351451)

  • 1. Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848.
    Tchelebi LT; Winter KA; Abrams RA; Safran HP; Regine WF; McNulty S; Wu A; Du KL; Seaward SA; Bian SX; Aljumaily R; Shivnani A; Knoble JL; Crocenzi TS; DiPetrillo TA; Roof KS; Crane CH; Goodman KA
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):107-114. PubMed ID: 37598723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy quality assurance in paediatric clinical trials: first report from six QUARTET-affiliated trials.
    Kelly SM; Turcas A; Corning C; Bailey S; Cañete A; Clementel E; di Cataldo A; Dieckmann K; Gaze MN; Horan G; Jenney M; Ladenstein R; Padovani L; Valteau-Couanet D; Boterberg T; Mandeville H
    Radiother Oncol; 2023 May; 182():109549. PubMed ID: 36828140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331).
    Schiff JP; Lee Y; Wang Y; Perkins SM; Kessel SK; Fitzgerald TJ; Larrier NA; Michalski JM
    Adv Radiat Oncol; 2023; 8(1):101083. PubMed ID: 36483060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national repository of complete radiotherapy plans: design, Results, and experiences.
    Krogh SL; Brink C; Lorenzen EL; Samsøe E; Vogelius IR; Zukauskaite R; Vrou Offersen B; Eriksen JG; Hansen O; Johansen J; Olloni A; Ruhlmann CH; Hoffmann L; Nissen HD; Skovmos Nielsen M; Andersen K; Grau C; Hansen CR
    Acta Oncol; 2023 Oct; 62(10):1161-1168. PubMed ID: 37850659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial.
    Bailey S; André N; Gandola L; Massimino M; Wheatley K; Gates S; Homer V; Rutkowski S; Clifford SC
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgroup and subtype-specific outcomes in adult medulloblastoma.
    Coltin H; Sundaresan L; Smith KS; Skowron P; Massimi L; Eberhart CG; Schreck KC; Gupta N; Weiss WA; Tirapelli D; Carlotti C; Li KKW; Ryzhova M; Golanov A; Zheludkova O; Absalyamova O; Okonechnikov K; Stichel D; von Deimling A; Giannini C; Raskin S; Van Meir EG; Chan JA; Fults D; Chambless LB; Kim SK; Vasiljevic A; Faure-Conter C; Vibhakar R; Jung S; Leary S; Mora J; McLendon RE; Pollack IF; Hauser P; Grajkowska WA; Rubin JB; van Veelen MC; French PJ; Kros JM; Liau LM; Pfister SM; Kool M; Kijima N; Taylor MD; Packer RJ; Northcott PA; Korshunov A; Ramaswamy V
    Acta Neuropathol; 2021 Nov; 142(5):859-871. PubMed ID: 34409497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors.
    Sievers P; Henneken SC; Blume C; Sill M; Schrimpf D; Stichel D; Okonechnikov K; Reuss DE; Benzel J; Maaß KK; Kool M; Sturm D; Zheng T; Ghasemi DR; Kohlhof-Meinecke P; Cruz O; Suñol M; Lavarino C; Ruf V; Boldt HB; Pagès M; Pouget C; Schweizer L; Kranendonk MEG; Akhtar N; Bunkowski S; Stadelmann C; Schüller U; Mueller WC; Dohmen H; Acker T; Harter PN; Mawrin C; Beschorner R; Brandner S; Snuderl M; Abdullaev Z; Aldape K; Gilbert MR; Armstrong TS; Ellison DW; Capper D; Ichimura K; Reifenberger G; Grundy RG; Jabado N; Krskova L; Zapotocky M; Vicha A; Varlet P; Wesseling P; Rutkowski S; Korshunov A; Wick W; Pfister SM; Jones DTW; von Deimling A; Pajtler KW; Sahm F
    Acta Neuropathol; 2021 Nov; 142(5):827-839. PubMed ID: 34355256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives.
    Seidel C; Heider S; Hau P; Glasow A; Dietzsch S; Kortmann RD
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dedicated cloud system for real-time upfront quality assurance in pediatric radiation therapy.
    Meroni S; Cavatorta C; Barra S; Cavagnetto F; Scarzello G; Scaggion A; Pecori E; Diletto B; Alessandro O; Massimino M; Gianolini S; Pignoli E; Gandola L
    Strahlenther Onkol; 2019 Sep; 195(9):843-850. PubMed ID: 31025053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
    Müller RP; Eich HT
    Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial.
    Bailey S; André N; Gandola L; Massimino M; Wheatley K; Gates S; Homer V; Rutkowski S; Clifford SC
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk Medulloblastoma.
    Mynarek M; Milde T; Padovani L; Janssens GO; Kwiecien R; Mosseri V; Clifford SC; Doz F; Rutkowski S
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial.
    Dietzsch S; Braesigk A; Seidel C; Remmele J; Kitzing R; Schlender T; Mynarek M; Geismar D; Jablonska K; Schwarz R; Pazos M; Weber DC; Frick S; Gurtner K; Matuschek C; Harrabi SB; Glück A; Lewitzki V; Dieckmann K; Benesch M; Gerber NU; Obrecht D; Rutkowski S; Timmermann B; Kortmann RD
    Strahlenther Onkol; 2022 Mar; 198(3):282-290. PubMed ID: 34351451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.
    Dietzsch S; Braesigk A; Seidel C; Remmele J; Kitzing R; Schlender T; Mynarek M; Geismar D; Jablonska K; Schwarz R; Pazos M; Walser M; Frick S; Gurtner K; Matuschek C; Harrabi SB; Glück A; Lewitzki V; Dieckmann K; Benesch M; Gerber NU; Rutkowski S; Timmermann B; Kortmann RD
    Strahlenther Onkol; 2021 Aug; 197(8):674-682. PubMed ID: 33226469
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.